1. Home
  2. ELUT vs EIIA Comparison

ELUT vs EIIA Comparison

Compare ELUT & EIIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ELUT
  • EIIA
  • Stock Information
  • Founded
  • ELUT 2015
  • EIIA N/A
  • Country
  • ELUT United States
  • EIIA
  • Employees
  • ELUT N/A
  • EIIA N/A
  • Industry
  • ELUT Medical Specialities
  • EIIA
  • Sector
  • ELUT Health Care
  • EIIA
  • Exchange
  • ELUT Nasdaq
  • EIIA Nasdaq
  • Market Cap
  • ELUT 94.0M
  • EIIA N/A
  • IPO Year
  • ELUT 2020
  • EIIA N/A
  • Fundamental
  • Price
  • ELUT $1.99
  • EIIA $24.62
  • Analyst Decision
  • ELUT Strong Buy
  • EIIA
  • Analyst Count
  • ELUT 2
  • EIIA 0
  • Target Price
  • ELUT $9.00
  • EIIA N/A
  • AVG Volume (30 Days)
  • ELUT 40.2K
  • EIIA N/A
  • Earning Date
  • ELUT 05-08-2025
  • EIIA N/A
  • Dividend Yield
  • ELUT N/A
  • EIIA N/A
  • EPS Growth
  • ELUT N/A
  • EIIA N/A
  • EPS
  • ELUT N/A
  • EIIA N/A
  • Revenue
  • ELUT $24,375,000.00
  • EIIA N/A
  • Revenue This Year
  • ELUT $39.35
  • EIIA N/A
  • Revenue Next Year
  • ELUT $61.26
  • EIIA N/A
  • P/E Ratio
  • ELUT N/A
  • EIIA N/A
  • Revenue Growth
  • ELUT N/A
  • EIIA N/A
  • 52 Week Low
  • ELUT $1.79
  • EIIA N/A
  • 52 Week High
  • ELUT $5.24
  • EIIA N/A
  • Technical
  • Relative Strength Index (RSI)
  • ELUT 39.97
  • EIIA N/A
  • Support Level
  • ELUT $1.79
  • EIIA N/A
  • Resistance Level
  • ELUT $2.07
  • EIIA N/A
  • Average True Range (ATR)
  • ELUT 0.20
  • EIIA 0.00
  • MACD
  • ELUT -0.00
  • EIIA 0.00
  • Stochastic Oscillator
  • ELUT 33.08
  • EIIA 0.00

About ELUT Elutia Inc.

Elutia Inc Formerly Aziyo Biologics Inc is a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, concentrating on patients receiving implantable medical devices. The company's segments include Device Protection, Women's Health and Cardiovascular. It generates maximum revenue from the Women's Health segment. The products of the company are targeted to address unmet clinical needs with the goal of promoting healthy tissue formation and avoiding complications associated with medical device implants, such as scar-tissue formation, capsular contraction, erosion, migration, non-union of implants and implant rejection.

About EIIA Eagle Point Institutional Income Fund

Eagle Point Institutional Income Fund is a closed-end investment company. Its investment objective is to generate high current income, with a secondary objective to generate capital appreciation.

Share on Social Networks: